Recent progress of exosomal lncRNA/circRNA–miRNA–mRNA axis in lung cancer: implication for clinical application
Open Access
- 3 July 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 11, 1417306
Abstract
Lung cancer is the leading cause of death among malignant tumors in the world. High lung cancer mortality rate is due to most of patients diagnosed at advanced stage. The Liquid biopsy of lung cancer have received recent interest for early diagnosis. One of the components of liquid biopsy is the exosome. The exosome cargos non-coding-RNAs, especially long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and microRNAs (miRNAs). The lung cancer derived exosomal non-coding RNAs play the pivotal roles of lung cancer in carcinogenesis, diagnosis, therapy, drug resistance and prognosis of lung cancer. Given ceRNA (competitive endogenous RNA) mechanism, lncRNA or circRNA can act as ceRNA to compete to bind miRNAs and alter the expression of the targeted mRNA, contributing to the development and progression of lung cancer. The current research progress of the roles of the exosomal non-coding-RNAs and the interplay of ceRNAs and miRNAs in mediated lung cancer is illustrated in this article. Hence, we presented an experimentally validated lung cancer derived exosomal non-coding RNAs-regulated target gene axis from already existed evidence in lung cancer. Then LncRNA/circRNA-miRNA-mRNA axis may be a potential target for lung cancer treatment and has great potential in the diagnosis and prognosis of lung cancer.Keywords
This publication has 65 references indexed in Scilit:
- Exosomal circ_0000735 contributes to non‐small lung cancer malignant progressionJournal of Biochemical and Molecular Toxicology, 2024
- Rapid automated extracellular vesicle isolation and miRNA preparation on a cost-effective digital microfluidic platformAnalytica Chimica Acta, 2024
- Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancerCancer Cell, 2024
- Advances and challenges in the treatment of lung cancerBiomedicine & Pharmacotherapy, 2023
- Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancerInternational Journal of Clinical Oncology, 2022
- Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axisMolecular and Cellular Biochemistry, 2021
- Serum exosomal miR‐7977 as a novel biomarker for lung adenocarcinomaJournal of Cellular Biochemistry, 2020
- Absolute quantification and analysis of extracellular vesicle lncRNAs from the peripheral blood of patients with lung cancer based on multi-colour fluorescence chip-based digital PCRBiosensors and Bioelectronics, 2019
- Tumor‐derived exosomal lncRNA GAS5 as a biomarker for early‐stage non‐small‐cell lung cancer diagnosisJournal of Cellular Physiology, 2019
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011